Blocking IL-8 activity has the potential to diminish the tumor-promoting signals for angiogenesis, neutrophil and MDSC activation/infiltration, EMT, as well as reducing bulk tumor growth and metastasis. This evidence concerns the gene CXCL8 and neoplasm.